• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

楔形切除术作为高危患者周围型支气管肺癌的替代手术。

Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients.

作者信息

Errett L E, Wilson J, Chiu R C, Munro D D

出版信息

J Thorac Cardiovasc Surg. 1985 Nov;90(5):656-61.

PMID:3932783
Abstract

Although lobectomy is the procedure of preference for patients with peripheral, clinical Stage I bronchogenic carcinomas, wedge resection of the tumor may be a satisfactory alternative in poor-risk patients. Between 1965 and 1982, 197 patients with peripheral bronchogenic carcinomas were operated upon. Clinical staging was established by radiography, bronchoscopy, and mediastinoscopy. Ninety-seven patients underwent lobectomies and 100 had wedge resections. The decision to perform the wedge resection was made preoperatively in the majority of cases based on the assessment of operative risks. Compared to lobectomy patients, those who had wedge resections were older (70.3 +/- 0.5 versus 64.9 +/- 0.5 years, p less than 0.001) and had a lower 1 second forced expiratory volume (1.56 +/- 0.03 versus 1.94 +/- 0.03 ml, p less than 0.001), a lower arterial oxygen tension (70.5 +/- 1.1 versus 75.6 +/- 1.2 mm Hg, p less than 0.01), and a higher arterial carbon dioxide tension (41.7 +/- 0.6 versus 38.7 +/- 0.3 mm Hg, p less than 0.001). Despite their compromised preoperative respiratory functional status, the wedge resection group had a 30 day operative mortality (3% versus 2.1%) and morbidity comparable to those of the lobectomy group. Actuarial life-table analysis indicates the cumulative survival rate at 2 years after operation to be virtually identical between wedge and lobectomy groups (72% versus 74%), and even at 6 years the differences in survival rates (69% versus 75%) were not statistically significant. We conclude, therefore, that by performing wedge resections in selected poor-risk patients, one may reduce the operative mortality and morbidity to an acceptable range without seriously compromising their long-term survival.

摘要

虽然肺叶切除术是外周型临床I期支气管癌患者的首选手术方式,但对于手术风险高的患者,肿瘤楔形切除术可能是一种令人满意的替代方法。1965年至1982年间,对197例外周型支气管癌患者进行了手术。通过放射学、支气管镜检查和纵隔镜检查进行临床分期。97例患者接受了肺叶切除术,100例进行了楔形切除术。大多数病例术前根据手术风险评估决定进行楔形切除术。与肺叶切除术患者相比,接受楔形切除术的患者年龄更大(70.3±0.5岁对64.9±0.5岁,p<0.001),第1秒用力呼气量更低(1.56±0.03对1.94±0.03 ml,p<0.001),动脉血氧分压更低(70.5±1.1对75.6±1.2 mmHg,p<0.01),动脉血二氧化碳分压更高(41.7±0.6对38.7±0.3 mmHg,p<0.001)。尽管楔形切除术组患者术前呼吸功能状态较差,但该组30天手术死亡率(3%对2.1%)和发病率与肺叶切除术组相当。精算生命表分析表明,楔形切除术组和肺叶切除术组术后2年的累积生存率几乎相同(72%对74%),甚至在6年时生存率差异(69%对75%)也无统计学意义。因此,我们得出结论,通过对选定的手术风险高的患者进行楔形切除术,可以将手术死亡率和发病率降低到可接受的范围,而不会严重影响其长期生存。

相似文献

1
Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients.楔形切除术作为高危患者周围型支气管肺癌的替代手术。
J Thorac Cardiovasc Surg. 1985 Nov;90(5):656-61.
2
Additional pulmonary resections after pneumonectomy: actual long-term survival and functional results.肺切除术后的额外肺切除术:实际长期生存率和功能结果。
Eur J Cardiothorac Surg. 2008 Sep;34(3):493-8. doi: 10.1016/j.ejcts.2008.05.023. Epub 2008 Jun 25.
3
Lung resection for bronchogenic carcinoma after pneumonectomy: a safe and worthwhile procedure.肺切除术后行支气管源性癌肺切除术:一种安全且值得进行的手术。
Eur J Cardiothorac Surg. 2004 Mar;25(3):456-9. doi: 10.1016/j.ejcts.2003.12.024.
4
Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.非小细胞肺癌袖状肺叶切除术后的发病率、死亡率和长期生存率
Eur J Cardiothorac Surg. 2007 Jan;31(1):95-102. doi: 10.1016/j.ejcts.2006.10.031. Epub 2006 Nov 28.
5
["Intentionally" limited pulmonary resection versus lobectomy for the treatment of peripheral stage IA non-small cell lung cancers].["意向性"肺叶切除术与肺叶切除术治疗周围型ⅠA期非小细胞肺癌的对比]
G Chir. 2007 Jan-Feb;28(1-2):7-12.
6
Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study.高危患者周围型肺癌的电视辅助楔形切除术及局部放疗:癌症与白血病B组(CALGB)9335研究,一项II期多机构合作组研究
J Thorac Cardiovasc Surg. 2005 Apr;129(4):813-8. doi: 10.1016/j.jtcvs.2004.05.011.
7
Pulmonary resections in patients over 70 years of age.70岁以上患者的肺切除术。
Isr J Med Sci. 1985 Oct;21(10):833-40.
8
[Comparison of typical and atypical bronchoplasty for bronchogenic carcinoma].[典型与非典型支气管成形术治疗支气管源性癌的比较]
Kyobu Geka. 1993 Mar;46(3):197-201; discussion 202-5.
9
Resection for bronchogenic carcinoma involving the carina: long-term results and effect of nodal status on outcome.累及隆突的支气管源性癌切除术:长期结果及淋巴结状态对预后的影响
J Thorac Cardiovasc Surg. 2001 Mar;121(3):465-71. doi: 10.1067/mtc.2001.112832.
10
Survival after resection of synchronous bilateral lung cancer.同步性双侧肺癌切除术后的生存情况。
Eur J Cardiothorac Surg. 2008 Dec;34(6):1215-22. doi: 10.1016/j.ejcts.2008.07.069. Epub 2008 Oct 1.

引用本文的文献

1
Saving Lives in Thoracic Surgery: Balancing Oncological Radicality and Functional Preservation, Transitioning from Standard Pneumonectomy to Targeted Sublobar Resection.胸外科的挽救生命:平衡肿瘤根治性与功能保留,从标准肺切除术向靶向亚肺叶切除术的转变。
Cancers (Basel). 2024 Feb 18;16(4):819. doi: 10.3390/cancers16040819.
2
Is segmentectomy the future?肺段切除术是未来的发展方向吗?
J Thorac Dis. 2019 Jan;11(1):308-318. doi: 10.21037/jtd.2018.12.67.
3
Optimal sublobar resection for c-stage I non-small cell lung cancer: significance of margin distance to tumor size ratio and margin cytology (Supplementary analysis of KLSG-0801): complete republication.
c期I期非小细胞肺癌的最佳亚肺叶切除术:切缘距离与肿瘤大小比值及切缘细胞学的意义(韩国肺癌研究组KLSG-0801补充分析):全文重新发表
Gen Thorac Cardiovasc Surg. 2019 Aug;67(8):690-696. doi: 10.1007/s11748-019-01069-8. Epub 2019 Feb 19.
4
Surgical Management of Lung Cancer: History, Evolution, and Modern Advances.肺癌的外科治疗:历史、演变和现代进展。
Curr Oncol Rep. 2018 Nov 13;20(12):98. doi: 10.1007/s11912-018-0741-7.
5
Validating margin status in lung wedge resection for clinical stage I non-small cell lung cancer.验证临床 I 期非小细胞肺癌肺楔形切除术中切缘状态
Surg Today. 2018 Oct;48(10):963-967. doi: 10.1007/s00595-018-1683-2. Epub 2018 Jun 19.
6
Emerging treatment options in the management of non-small cell lung cancer.非小细胞肺癌治疗中的新兴治疗选择。
Lung Cancer (Auckl). 2011 Jun 8;2:11-28. doi: 10.2147/LCTT.S8618. eCollection 2011.
7
Management and postoperative outcome in primary lung cancer and heart disease co-morbidity: a systematic review and meta-analysis.原发性肺癌合并心脏病患者的管理和术后结局:系统评价和荟萃分析。
Ann Transl Med. 2016 Jun;4(11):213. doi: 10.21037/atm.2016.06.02.
8
Multicenter prospective study of sublobar resection for c-stage I non-small cell lung cancer patients unable to undergo lobectomy (KLSG-0801): complete republication.无法接受肺叶切除术的c期I非小细胞肺癌患者亚肺叶切除术的多中心前瞻性研究(KLSG-0801):完整再发表
Gen Thorac Cardiovasc Surg. 2016 Aug;64(8):470-5. doi: 10.1007/s11748-016-0662-z. Epub 2016 May 27.
9
Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients.高危/医学上无法手术的早期非小细胞肺癌患者的主要治疗选择
Clin Lung Cancer. 2015 Nov;16(6):413-30. doi: 10.1016/j.cllc.2015.04.001. Epub 2015 Apr 23.
10
Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma.I期非小细胞肺癌患者的楔形切除术和肺段切除术
Oncol Rev. 2014 Sep 23;8(2):234. doi: 10.4081/oncol.2014.234.